Explore more Articles in

BioTech

US Dollar May Weaken Due to Tariffs, Debt, and Economic Data

Although last week’s US (Non-Farm Payrolls) data beat expectations and gave a slight boost, the rise was not strong enough to change...

Oil Market Shrugs Off OPEC+ Output Increase Amid Strong Demand

Last week, I covered solar energy.   I still say that all energy hands will be needed on deck to support the demands of AI, not...

Oil Market Shrugs Off OPEC+ Supply Increase

managed to settle higher yesterday despite the announced supply increase from OPEC+ Energy – Oil Rallies Despite OPEC+ Supply Increase While prices initially slid yesterday...

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness...
BioTech

Two Biotech Stocks Poised For Big Moves On Monday – Lineage Cell Therapeutics (AMEX:LCTX), Roche Holding (OTC:RHHBY)

Two Biotechs Poised For Big Moves On Monday(Sana Biotechnology | Lineage Cell Therapeutics)1️⃣ Sana BiotechnologySana Biotechnology, Inc. SANACatalyst: Invited six-month clinical update — ADA...
BioTech

Exelixis Targets $5 Billion In Sales With Promising Data In Key Colorectal Cancer Drug Trial, Stock Soars – Exelixis (NASDAQ:EXEL)

On Sunday, Exelixis, Inc. EXEL revealed topline results from the STELLAR-303 phase 3 pivotal trial of zanzalintinib (100 mg) combined with atezolizumab.The study includes...
BioTech

Why Is Compass Pathways Stock Trading Lower On Monday? – Compass Pathways (NASDAQ:CMPS)

Compass Pathways plc CMPS released data from the Phase 3 COMP005 trial, the first of two Phase 3 trials evaluating COMP360 for treatment-resistant depression...
BioTech

Zhengye Biotechnology Stock Is Trading Lower On Monday: What’s Going On? – Zhengye Biotechnology (NASDAQ:ZYBT)

Zhengye Biotechnology Holding ZYBT shares are trading lower after the company announced it received a Nasdaq noncompliance notice.What To Know: Zhengye said it received...
BioTech

Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update – Amgen (NASDAQ:AMGN)

Amgen Inc AMGN shares are trading lower by 5.7% to $272.88 Monday afternoon after the company released full results from part one of its...
BioTech

Merck’s Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy – Merck & Co (NYSE:MRK)

Merck & Co., Inc. MRK on Monday announced positive topline results from the Phase 3 HYPERION study evaluating Winrevair (sotatercept-csrk) versus placebo (both in...
1...111213...18Page 12 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.